| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/01/1998 | EP0832278A1 Linked linear amplification of nucleic acids |
| 04/01/1998 | EP0832277A1 Method of transferring at least two saccharide units with a polyglycosyltransferase |
| 04/01/1998 | EP0832273A1 Synthetic mammalian chromosome and methods for construction |
| 04/01/1998 | EP0832272A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832271A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 04/01/1998 | EP0832270A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832269A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 04/01/1998 | EP0832268A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 04/01/1998 | EP0832267A1 Adenovirus vectors for gene therapy |
| 04/01/1998 | EP0832266A1 Oral delivery of adeno-associated viral vectors |
| 04/01/1998 | EP0832265A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0832264A1 Plasmid for delivery of nucleic acids to cells and methods of use |
| 04/01/1998 | EP0832263A1 Methods and constructs for producing male sterile plants |
| 04/01/1998 | EP0832262A1 Modification of plant lipids and seed oils utilizing yeast slc genes |
| 04/01/1998 | EP0832261A2 Induction of male sterility in plants by expression of high levels of avidin |
| 04/01/1998 | EP0832260A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 04/01/1998 | EP0832259A1 Transformed embryogenic microspores for the generation of fertile homozygous plants |
| 04/01/1998 | EP0832258A1 Upstream activator sequences and recombinant promoter sequences functional in yarrowia and vectors containing them |
| 04/01/1998 | EP0832257A1 A dna molecule for expression of bile salt-stimulated lipase (bssl) |
| 04/01/1998 | EP0832256A1 Compositions for expression of proteins in host cells using a preprocollagen signal sequence |
| 04/01/1998 | EP0832255A1 Recombinant bacterial system with environmentally limited viability |
| 04/01/1998 | EP0832254A1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
| 04/01/1998 | EP0832253A2 Nucleic acid respiratory syncytial virus vaccines |
| 04/01/1998 | EP0832252A1 Use of gram-positive bacteria to express recombinant proteins |
| 04/01/1998 | EP0832251A1 Human ice homolog |
| 04/01/1998 | EP0832250A2 MUTANT $g(a)-AMYLASE |
| 04/01/1998 | EP0832249A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 04/01/1998 | EP0832248A2 Expression of functional vertebrate phospholipases in yeast |
| 04/01/1998 | EP0832247A1 Process to increase the production of clavam antibiotics |
| 04/01/1998 | EP0832246A1 Expression of human inducible nitric oxide synthase |
| 04/01/1998 | EP0832245A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 04/01/1998 | EP0832244A1 Polyphenol oxidase genes from lettuce and banana |
| 04/01/1998 | EP0832243A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
| 04/01/1998 | EP0832242A1 Neutralizing conformational epitopes of chicken anemia virus |
| 04/01/1998 | EP0832241A1 Mutants of streptococcal toxin a and methods of use |
| 04/01/1998 | EP0832240A1 Cloning and expression of thermostable muts genes and proteins and uses therefor |
| 04/01/1998 | EP0832239A1 Camp factor of streptococcus uberis |
| 04/01/1998 | EP0832238A1 Streptococcal heat shock proteins members of the hsp70 family |
| 04/01/1998 | EP0832237A1 Isospora suis vaccine |
| 04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
| 04/01/1998 | EP0832235A1 HIGH METHIONINE DERIVATIVES OF alfa-HORDOTHIONIN |
| 04/01/1998 | EP0832234A2 Genetic control of flowering |
| 04/01/1998 | EP0832233A1 Human chemokine beta-13 |
| 04/01/1998 | EP0832232A1 Kunitz type plasma kallikrein inhibitors |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832230A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 04/01/1998 | EP0832229A2 Cd40l mutein |
| 04/01/1998 | EP0832228A1 Modified hemoglobin-like compounds and methods of purifying same |
| 04/01/1998 | EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 04/01/1998 | EP0832226A2 Ebnerin cloning of a secreted von ebner's gland protein |
| 04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832222A2 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 04/01/1998 | EP0832221A1 Bone stimulating factor |
| 04/01/1998 | EP0832220A1 Ob protein compositions and method |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832218A1 Avian ghd genes and their use in methods for sex identification in birds |
| 04/01/1998 | EP0832217A1 Modified steroid hormones for gene therapy and methods for their use |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832214A2 Oligonucleotides specific for human papillomavirus |
| 04/01/1998 | EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 04/01/1998 | EP0832212A1 Intergenic regions of banana bunchy top virus |
| 04/01/1998 | EP0832211A1 Oligonucleotides specific for hepatitis b virus |
| 04/01/1998 | EP0832210A1 Nucleic acid repair enzyme methods for point mutation detection and in vitro mutagenesis |
| 04/01/1998 | EP0832209A1 Secretion leader trap cloning method |
| 04/01/1998 | EP0832208A1 Materials and methods for the polymerase chain reaction |
| 04/01/1998 | EP0832207A1 A method for identification of biologically active peptides and nucleic acids |
| 04/01/1998 | EP0832206A2 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris |
| 04/01/1998 | EP0832205A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832203A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 04/01/1998 | EP0832202A1 Aav directed targeted integration |
| 04/01/1998 | EP0832199A1 Fucosyltransferase genes and uses thereof |
| 04/01/1998 | EP0832197A1 Recombinant fowlpox viruses and uses thereof |
| 04/01/1998 | EP0832196A1 Immortalization and disimmortalization of cells |
| 04/01/1998 | EP0832191A1 Recombinant viral nucleic acids |
| 04/01/1998 | EP0832190A1 Essential oligonucleotides of vertebrate telomerase |
| 04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 04/01/1998 | EP0832186A1 Replacement therapy for dental caries |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
| 04/01/1998 | EP0832128A2 Thrombin receptor homolog |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832124A1 Human amine receptor |
| 04/01/1998 | EP0832123A1 G-protein parathyroid hormone receptor hltdg74 |
| 04/01/1998 | EP0832122A1 Human g-protein receptor hpraj70 |
| 04/01/1998 | EP0832121A1 Methods for purifying authentic igf from yeast hosts |
| 04/01/1998 | EP0832119A2 Anti-fungal and anti-bacterial histatin-based peptides |
| 04/01/1998 | EP0832118A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 04/01/1998 | EP0832117A1 Ligand-stimulated gene expression |
| 04/01/1998 | EP0832116A1 New dna molecules |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832098A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 04/01/1998 | EP0832093A1 Expression of lipoproteins |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831931A1 An in vivo and in vitro model of cutaneous photoaging |